Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0162871 (
abdominal aortic aneurysm
)
8,664
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It is established that prolonged hypoxia leads to activation of K(ATP) channels and action potential (AP) shortening, but the mechanisms behind the early phase of metabolic stress remain controversial. Under normal conditions
IK1
channels are constitutively active while K(ATP) channels are closed. Therefore, early changes in
IK1
may underlie early AP shortening. This hypothesis was tested using transgenic mice with suppressed
IK1
(
AAA
-TG). In isolated
AAA
-TG hearts AP shortening was delayed by approximately 24 s compared to WT hearts. In WT ventricular myocytes, blocking oxidative phosphorylation with 1 mM cyanide (CN; 28 degrees C) led to a 29% decrease in APD90 within approximately 3-5 min. The effect of CN was reversed by application of 100 microM Ba2+, a selective blocker of
IK1
, but not by 10 microM glybenclamide, a selective blocker of KATP channels. Accordingly, voltage-clamp experiments revealed that both CN and true hypoxia lead to early activation of
IK1
. In
AAA
-TG myocytes, neither CN nor glybenclamide or Ba2+ had any effect on AP. Further experiments showed that buffering of intracellular Ca2+ with 20 mM BAPTA prevented
IK1
activation by CN, although CN still caused a 54% increase in
IK1
in a Ca2+ -free bath solution. Importantly, both (i) 20 microM ruthenium red, a selective inhibitor of SR Ca2+ -release, and (ii) depleting SR by application of 10 microM ryanodine+1 mM caffeine, abolished the activation of
IK1
by CN. The above data strongly argue that in the mouse heart
IK1
, not KATP, channels are responsible for the early AP shortening during hypoxia.
...
PMID:Cardiac IK1 underlies early action potential shortening during hypoxia in the mouse heart. 1756 Nov 8
The role of the cardiac current Ik1 in arrhythmogenesis remains highly controversal. To gain further insights into the mechanisms of
IK1
involvement in cardiac excitability, we studied the susceptibility of transgenic mice with altered
IK1
to arrhythmia during various pharmacological and physiological challenges. Arrhythmogenesis was studied in transgenic mice expressing either dominant negative Kir2.1-
AAA
or wild type Kir2.1 subunits in the heart, models of
IK1
suppression (
AAA
-TG) and up-regulation (WT-TG), respectively. Under normal conditions, both anesthetized wild type (WT) and
AAA
-TG mice did not display any spontaneous arrhythmias. In contrast,WT-TG mice displayed numerous arrhythmias of various types. In isolated hearts, the threshold concentration for halothane-induced ventricular tachycardias (VT) was increased to 167% [corrected] in the
AAA
-TG and decreased to 54% [corrected] in WT-TG hearts when compared to WT hearts. The number of PVCs induced by AV node ablation combined with hypokalemia was reduced in
AAA
-TG hearts and increased in WT-TG mice. After AV node ablation
AAA
-TG hearts were more tolerant, and WT-TG less tolerant to isoproterenol- induced arrhythmias than WT hearts. Analysis of monophasic action potentials in isolated hearts shows a significant reduction in the dispersion of action potential repolarization in mice with suppressed
IK1
. The data strongly support the hypothesis that in the mouse heart upregulation of
IK1
is proarrhythmic, and that under certain conditions
IK1
blockade in cardiac myocytes may be a potentially useful antiarrhythmic strategy.
...
PMID:Transgenic upregulation of IK1 in the mouse heart is proarrhythmic. 1754 30
The intermediate-conductance calcium-activated potassium channel (
IK1
) promotes cell proliferation of numerous cell types including endothelial cells, T lymphocytes, and several cancer cell lines. The mechanism underlying
IK1
-mediated cell proliferation was examined in human embryonic kidney 293 (HEK293) cells expressing recombinant human
IK1
(hIK1) channels. Inhibition of hIK1 with TRAM-34 reduced cell proliferation, while expression of hIK1 in HEK293 cells increased proliferation. When HEK293 cells were transfected with a mutant (GYG/
AAA
) hIK1 channel, which neither conducts K(+) ions nor promotes Ca(2+) entry, proliferation was increased relative to mock-transfected cells. Furthermore, when HEK293 cells were transfected with a trafficking mutant (L18A/L25A) hIK1 channel, proliferation was also increased relative to control cells. The lack of functional activity of hIK1 mutants at the cell membrane was confirmed by a combination of whole cell patch-clamp electrophysiology and fura-2 imaging to assess store-operated Ca(2+) entry and cell surface immunoprecipitation assays. Moreover, in cells expressing hIK1, inhibition of ERK1/2 and JNK kinases, but not of p38 MAP kinase, reduced cell proliferation. We conclude that functional K(+) efflux at the plasma membrane and the consequent hyperpolarization and enhanced Ca(2+) entry are not necessary for hIK1-induced HEK293 cell proliferation. Rather, our data suggest that hIK1-induced proliferation occurs by a direct interaction with ERK1/2 and JNK signaling pathways.
...
PMID:Calcium-activated K+ channels increase cell proliferation independent of K+ conductance. 2112 38